| 03/02/25 | 07:00:07 | 3 Feb 2025 | | Inaphaea Evaluation and Commercial Use Agreement |
| 30/01/25 | 07:00:04 | 30 Jan 2025 | | Extension of Evaluation Agreement |
| 29/01/25 | 07:00:06 | 29 Jan 2025 | | New Evaluation and Option Agreement |
| 15/01/25 | 12:47:22 | 15 Jan 2025 | | Holding(s) in Company |
| 15/01/25 | 11:29:18 | 15 Jan 2025 | | Holding(s) in Company |
| 14/01/25 | 07:00:07 | 14 Jan 2025 | | Holding(s) in Company |
| 09/01/25 | 11:37:14 | 9 Jan 2025 | | Holding(s) in Company |
| 09/01/25 | 11:14:49 | 9 Jan 2025 | | Holding(s) in Company |
| 08/01/25 | 07:00:05 | 8 Jan 2025 | | Holding(s) in Company |
| 02/01/25 | 11:45:50 | 2 Jan 2025 | | Holding(s) in Company |
| 31/12/24 | 13:06:18 | 31 Dec 2024 | | Holding(s) in Company |
| 31/12/24 | 08:39:48 | 31 Dec 2024 | | Update on proposed sub-license of VAL201 |
| 30/12/24 | 13:30:00 | 30 Dec 2024 | | Result of GM, Issue of Equity, Warrants and TVR |
| 20/12/24 | 07:00:09 | 20 Dec 2024 | | ValiRx launches new interactive investor website |
| 10/12/24 | 16:45:00 | 10 Dec 2024 | | Broker Offer Results & Director/PDMR Subscription |
| 10/12/24 | 15:03:42 | 10 Dec 2024 | | Posting of Circular and Notice of General Meeting |
| 09/12/24 | 07:00:04 | 9 Dec 2024 | | Conditional Fundraising & Launch of Broker Offer |
| 22/11/24 | 07:00:05 | 22 Nov 2024 | | Inaphaea award of HEIF Funding and PhD sponsorship |
| 20/11/24 | 07:00:07 | 20 Nov 2024 | | Update on proposed sub-license of VAL401 |
| 19/11/24 | 07:00:08 | 19 Nov 2024 | | Contract Award |
| 18/11/24 | 07:00:04 | 18 Nov 2024 | | First Sale of New Product Line |
| 30/10/24 | 07:00:08 | 30 Oct 2024 | | Update on proposed sub-license of VAL201 |
| 18/10/24 | 07:00:05 | 18 Oct 2024 | | Directorate Change |
| 14/10/24 | 07:00:05 | 14 Oct 2024 | | Investor Webinar |
| 07/10/24 | 07:00:05 | 7 Oct 2024 | | Inaphaea Co-Marketing Agreement |
| 27/09/24 | 07:00:02 | 27 Sept 2024 | | Half-year Report |
| 26/09/24 | 07:00:03 | 26 Sept 2024 | | Conclusion of Evaluation Project |
| 24/09/24 | 07:00:09 | 24 Sept 2024 | | Inaphaea Co-Marketing Agreement |
| 18/09/24 | 07:00:04 | 18 Sept 2024 | | Inaphaea Evaluation and Commercial Use Agreement |
| 16/09/24 | 07:00:06 | 16 Sept 2024 | | Inaphaea Co-Marketing Agreement |
| 09/09/24 | 07:00:05 | 9 Sept 2024 | | Inaphaea Evaluation and Commercial Use Agreement |
| 09/09/24 | 07:00:03 | 9 Sept 2024 | | Investor Evening |
| 27/08/24 | 07:00:12 | 27 Aug 2024 | | Inaphaea Evaluation and Commercial Use Agreement |
| 12/08/24 | 07:00:07 | 12 Aug 2024 | | Directorate Change |
| 25/07/24 | 07:00:13 | 25 Jul 2024 | | Directorate Changes |
| 03/07/24 | 08:51:54 | 3 Jul 2024 | | Proposed Director Appointment |
| 20/06/24 | 17:56:20 | 20 Jun 2024 | | Result of AGM |
| 19/06/24 | 11:33:31 | 19 Jun 2024 | | Directorate Change |
| 17/06/24 | 07:00:10 | 17 Jun 2024 | | Inaphaea Contract Award |
| 28/05/24 | 07:00:18 | 28 May 2024 | | Investor Webinar |
| 20/05/24 | 12:00:00 | 20 May 2024 | | Business Update |
| 16/05/24 | 07:00:08 | 16 May 2024 | | Further re Final Results |
| 15/05/24 | 07:00:10 | 15 May 2024 | | Final Results and Notice of AGM |
| 22/04/24 | 07:00:11 | 22 Apr 2024 | | Directorate Changes |
| 21/03/24 | 07:00:10 | 21 Mar 2024 | | Evaluation Agreement with Imperial College London |
| 19/03/24 | 07:00:08 | 19 Mar 2024 | | Board Re-structuring and update on requisition |
| 04/03/24 | 17:47:36 | 4 Mar 2024 | | Shareholder Requisition Notice |
| 04/03/24 | 07:00:07 | 4 Mar 2024 | | Proposed Appointment of Non-Executive Director |
| 29/02/24 | 14:00:00 | 29 Feb 2024 | | Proposed Appointment of Non-Executive Director |
| 13/02/24 | 14:20:24 | 13 Feb 2024 | | Further re Shareholder Requisition Notice |
